Rapport Therapeutics cover photo
Rapport Therapeutics

Rapport Therapeutics

生物技术研究

Precision medicines to match the complexity of the human brain.

关于我们

Rapport Therapeutics aims to transform the treatment of neurological disorders through a precision medicine approach, precisely targeting disease-driving neurocircuits by leveraging receptor-associated proteins (RAPs). With this approach, Rapport can overcome the well-established limitations of today’s neuromedicines that act indiscriminately throughout the nervous system, resulting in suboptimal efficacy and burdensome side effects. Leading the hunt for precision medicines is a team with established track records of innovation in neuroscience and drug discovery. Rapport was conceptualized and created through a partnership between Third Rock Ventures and Johnson & Johnson Innovation-JJDC, Inc. (JJDC) and launched in March 2023. Rapport is based in San Diego, CA and Boston, MA. For more information, please visit www.rapportrx.com.

网站
https://www.rapportrx.com
所属行业
生物技术研究
规模
11-50 人
总部
Boston, Massachusetts
类型
私人持股
创立
2022

地点

Rapport Therapeutics员工

动态

相似主页

查看职位

融资